Literature DB >> 2184158

Antimycotic effects of octenidine and pirtenidine.

M A Ghannoum1, K A Elteen, M Ellabib, P A Whittaker.   

Abstract

The effects of octenidine and pirtenidine on yeasts (in particular Candida albicans) have been studied. MIC and MCC values have been established as well as the inhibitory effects on growth, budding and germ tube formation. The drugs were shown to cause extensive leakage of cytoplasmic contents from the cells which was correlated with morphological and ultrastructural changes in the yeast.

Entities:  

Mesh：

Substances：

Year:  1990        PMID： 2184158     DOI： 10.1093/jac/25.2.237

Source DB:  PubMed          Journal:  J Antimicrob Chemother        ISSN： 0305-7453            Impact factor:   5.790


  7 in total

1.  Voriconazole (UK-109,496) inhibits the growth and alters the morphology of fluconazole-susceptible and -resistant Candida species.

Authors:  P Belanger; C C Nast; R Fratti; H Sanati; M Ghannoum
Journal:  Antimicrob Agents Chemother       Date:  1997-08       Impact factor: 5.191

2.  The effect of a combination of 0.1% octenidine dihydrochloride and 2% 2-phenoxyethanol (octenisept) on wound healing in pigs in vivo and its in vitro percutaneous permeation through intact and barrier disrupted porcine skin.

Authors:  Jessica Stahl; Michael Braun; Joerg Siebert; Manfred Kietzmann
Journal:  Int Wound J       Date:  2010-02       Impact factor: 3.315

3.  Thrombin-induced rabbit platelet microbicidal protein is fungicidal in vitro.

Authors:  M R Yeaman; A S Ibrahim; J E Edwards; A S Bayer; M A Ghannoum
Journal:  Antimicrob Agents Chemother       Date:  1993-03       Impact factor: 5.191

4.  Antibacterial and antiplaque efficacy of a commercially available octenidine-containing mouthrinse.

Authors:  Alexander Welk; Maral Zahedani; Carolin Beyer; Axel Kramer; Gerald Müller
Journal:  Clin Oral Investig       Date:  2015-11-10       Impact factor: 3.573

5.  The percutaneous permeation of a combination of 0.1% octenidine dihydrochloride and 2% 2-phenoxyethanol (octenisept®) through skin of different species in vitro.

Authors:  Jessica Stahl; Michael Braun; Joerg Siebert; Manfred Kietzmann
Journal:  BMC Vet Res       Date:  2011-08-11       Impact factor: 2.741

6. 

Authors:  J Köhnlein; F V Rheinbaben; S Werner
Journal:  Krankenhaushyg Infektionsverhut       Date:  2016-07-18

7.  Impact of 0.1% octenidine mouthwash on plaque re-growth in healthy adults: a multi-center phase 3 randomized clinical trial.

Authors:  Yvonne Jockel-Schneider; Ulrich Schlagenhauf; Hari Petsos; Stefan Rüttermann; Jana Schmidt; Dirk Ziebolz; Christian Wehner; Markus Laky; Thea Rott; Michael Noack; Barbara Noack; Katrin Lorenz
Journal:  Clin Oral Investig       Date:  2021-01-22       Impact factor: 3.573
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.